TRxADE HEALTH, Inc. entered into a binding letter of intent for a merger with Superlatus, Inc., with Superlatus shareholders receiving 3,839,176 shares of TRxADE HEALTH, Inc. valued at $58.61 per share.
AI Assistant
SCIENTURE HOLDINGS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.